Lipid Disorders in Children
Upon completion of this session, you should be able to:
1. Compare and contrast the familial and multifactorial dyslipidemias, and their clinical implications in children.
2. Explain the National Heart, Lung, and Blood Institute (NHBLI) Expert Panel on integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents.
3. Prescribe appropriate therapies for children identified as at risk for hyperlipidemia to aid I atherosclerotic disease prevention.
4. Prescribe appropriate management for children with severe hyperlipidemia.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Peter Ziemkowski, MD, FAAFP, Chair, Associate Dean for Student Affairs and Associate Professor, Department of Family and Community Medicine, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan
- 1.00 AAFP prescribed